Re-evaluating the role of palliative radiotherapy in malignant pleural mesothelioma
Authors:
- Peter JenkinsPJPeter Jenkins
- Rebecca MillinerRMRebecca Milliner
- Clare SalmonCSClare Salmon
- 1 September 2011
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 47 (14) , 2143-2149
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialThe Lancet, 2008
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Survival after conservative (palliative) management of pleural malignant mesotheliomaJournal of Surgical Oncology, 2001
- Phase II Study of Vinorelbine in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2000
- A phase II study of gemcitabine in patients with malignant pleural mesotheliomaCancer, 1999
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- Malignant mesothelioma in south east England: clinicopathological experience of 272 cases [published erratum appears in Thorax 1997 Nov;52(11):1018]Thorax, 1997
- Extrapleural Pneumonectomy in the Multimodality Therapy of Malignant Pleural MesotheliomaAnnals of Surgery, 1996
- Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.Journal of Clinical Oncology, 1989
- Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.Journal of Clinical Oncology, 1988